CKM will certainly help support the use of SGLT-2s in type 1 diabetes, Dutta said
In other words, be prepared to put in a lot of effort to convince your provider you really do need this medication
The factors that drive the global diabetes therapeutics market growth include rise in geriatric population, increase in the prevalence of diabetes worldwide, sedentary lifestyle of people, development of affordable & effective diabetes therapeutics, growth in awareness among population about self-management of diabetes, and increase in support from the government, the report said
GLP-1/GIP Receptor Dual Agonists Gastric inhibitory polypeptide (GIP) is a peptide hormone released by K-cells of the small intestine in response to food, which increases pancreatic insulin release
Wang Q, Liu Y, Zhou J
Restoring its effects with drugs that mimic its actions helps manage blood glucose